{"database": "openregs", "table": "federal_register", "rows": [["2012-22196", "New Animal Drugs; Chorionic Gonadotropin; Naloxone; Oxymorphone; Oxytocin", "Rule", "The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect the withdrawal of approval of four new animal drug applications (NADAs) at the sponsor's request because the products are no longer manufactured or marketed.", "2012-09-10", 2012, 9, "https://www.federalregister.gov/documents/2012/09/10/2012-22196/new-animal-drugs-chorionic-gonadotropin-naloxone-oxymorphone-oxytocin", "https://www.govinfo.gov/content/pkg/FR-2012-09-10/pdf/2012-22196.pdf", "Health and Human Services Department; Food and Drug Administration", "221,199", "The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect the withdrawal of approval of four new animal drug applications (NADAs) at the sponsor's request because the products are no longer manufactured or marketed.", null]], "columns": ["document_number", "title", "type", "abstract", "publication_date", "pub_year", "pub_month", "html_url", "pdf_url", "agency_names", "agency_ids", "excerpts", "regulation_id_numbers"], "primary_keys": ["document_number"], "primary_key_values": ["2012-22196"], "units": {}, "query_ms": 0.32988679595291615, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}